WAKIX is the first-and-only FDA-approved non-scheduled treatment option for excessive daytime sleepiness in pediatric patients 6 years of age and older with narcolepsy FDA granted priority review of ...
Source LinkWAKIX is the first-and-only FDA-approved non-scheduled treatment option for excessive daytime sleepiness in pediatric patients 6 years of age and older with narcolepsy FDA granted priority review of ...
Source Link
Comments